Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Neurology
|
May 16, 2007
CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies
J E C Bromberg, D A Breems, J Kraan, et al.
Blood
|
November 14, 1997
Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor eliminates acute myeloid leukemia cells with the potential to initiate leukemia in immunodeficient mice, but spares normal hemopoietic stem cells
W Terpstra, H Rozemuller, D A Breems, et al.
British Journal of Haematology
|
December 21, 2000
Stroma-supported progenitor production as a prognostic tool for graft failure following autologous stem cell transplantation
P B Van Hennik, D A Breems, N Kusadasi, et al.
Leukemia
|
November 28, 2014
Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years
J J Cornelissen, J Versluis, J R Passweg, et al.
Leukemia
|
February 6, 2020
Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
G J Ossenkoppele, D A Breems, G Stuessi, et al.
Leukemia
|
August 1, 2020
Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
G J Ossenkoppele, D A Breems, G Stuessi, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Neurology
|
May 16, 2007
CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies
J E C Bromberg, D A Breems, J Kraan, et al.
Blood
|
November 14, 1997
Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor eliminates acute myeloid leukemia cells with the potential to initiate leukemia in immunodeficient mice, but spares normal hemopoietic stem cells
W Terpstra, H Rozemuller, D A Breems, et al.
British Journal of Haematology
|
December 21, 2000
Stroma-supported progenitor production as a prognostic tool for graft failure following autologous stem cell transplantation
P B Van Hennik, D A Breems, N Kusadasi, et al.
Leukemia
|
November 28, 2014
Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years
J J Cornelissen, J Versluis, J R Passweg, et al.
Leukemia
|
February 6, 2020
Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
G J Ossenkoppele, D A Breems, G Stuessi, et al.
Leukemia
|
August 1, 2020
Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
G J Ossenkoppele, D A Breems, G Stuessi, et al.
Page
of 2